[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100546867":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":25,"responsibleParty":41,"collaborators":10,"id":44,"slug":10,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":47,"acronym":10,"eligibilityCriteria":48,"healthyVolunteers":45,"sex":49,"minAge":50,"maxAge":10,"enrollmentInfo":51,"targetDuration":10,"studyType":54,"phases":10,"briefSummary":55,"conditions":56,"keywords":10,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"University of Texas Southwestern Medical Center","OTHER",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"13C-glucose infusion",null,"Tumor samples of patients who receive the optional 13C-glucose infusion will be studied using flux analysis and metabolomic profiling.",{"label":13,"type":10,"description":14,"interventionNames":10},"No 13C-glucose infusion","Tumor samples of patients who do not receive the optional 13C-glucose infusion will be studied using metabolomic profiling alone.",[16],{"name":17,"affiliation":5,"role":18},"Jennifer Gill, MD, PhD","PRINCIPAL_INVESTIGATOR",[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Aleuna Lee","CONTACT","2146458968","aleuna.lee@utsouthwestern.edu",[26],{"facility":5,"status":27,"city":28,"state":29,"zip":30,"country":31,"countryCode":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Dallas","Texas","75390","United States","US",{"type":34,"coordinates":35},"Point",[36,37],-96.80667,32.78306,{"lat":37,"lon":36},[40],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},{"type":18,"investigatorFullName":42,"investigatorTitle":43,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Jennifer Gill","ASSISTANT PROFESSOR","100546867",false,"NCT06400550","Identification of Metabolic Phenotypes Associated With Melanoma Metastasis","Inclusion Criteria:\n\n* Patients with known or probable malignant melanoma lesions requiring surgical biopsy or excision.\n* Subjects of all races and ethnic origins over age 18.\n\nExclusion Criteria:\n\n* Not a surgical candidate\n* Poorly controlled diabetes","ALL","18 Years",{"count":52,"type":53},400,"ESTIMATED","OBSERVATIONAL","The goal of this study is to observe metabolic features associated with human melanoma tumors.",[57],"Melanoma (Skin)","2026-06-01",{"date":60,"type":61},"2026-06-02","ACTUAL",{"date":63,"type":61},"2018-08-01",{"date":65,"type":53},"2028-08-01",{"name":5,"class":6},1]